ABCL - AbCellera partners with PE firms to develop antibody drugs company creation May, 01 2024 11:44 AM AbCellera Biologics Inc. 2024-05-01 11:44:29 ET More on AbCellera Biologics AbCellera: Victim Of Its Own Success AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript AbCellera Biologics: Continuing To Expand Partnerships Peter Thiel resigns from AbCellera board for personal reasons For further details see: AbCellera partners with PE firms to develop antibody drugs, company creation